These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7650336)

  • 1. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis.
    Davies MH; Ngong JM; Pean A; Vickers CR; Waring RH; Elias E
    J Hepatol; 1995 May; 22(5):551-60. PubMed ID: 7650336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of poor sulfoxidation in patients with primary biliary cirrhosis.
    Olomu AB; Vickers CR; Waring RH; Clements D; Babbs C; Warnes TW; Elias E
    N Engl J Med; 1988 Apr; 318(17):1089-92. PubMed ID: 3281015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor sulphoxidation in primary biliary cirrhosis.
    Olomu A; Clements D; Waring R; Elias E
    Lancet; 1985 Jun; 1(8444):1504. PubMed ID: 2861427
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma cysteine and sulphate levels in patients with cirrhosis of the liver.
    Davies MH; Klovrza L; Waring RH; Elias E
    Clin Sci (Lond); 1994 Sep; 87(3):357-62. PubMed ID: 7955913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired sulfoxidation in primary biliary cirrhosis.
    Elias E; Waring R
    Hepatology; 1989 Dec; 10(6):1027. PubMed ID: 2583682
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal sulphur oxidation in systemic lupus erythematosus.
    Gordon C; Bradley H; Waring RH; Emery P
    Lancet; 1992 Jan; 339(8784):25-6. PubMed ID: 1345954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.
    Waring RH; Mitchell SC; O'Gorman J; Fraser M
    Biochem Pharmacol; 1986 Sep; 35(18):2999-302. PubMed ID: 3753512
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Mitchell SC; Waring RH; Haley CS; Idle JR; Smith RL
    Br J Clin Pharmacol; 1984 Oct; 18(4):507-21. PubMed ID: 6487492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.
    Watson RG; Olomu A; Clements D; Waring RH; Mitchell S; Elias E
    J Hepatol; 1988 Aug; 7(1):72-8. PubMed ID: 3183354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
    Biochem Pharmacol; 1982 Oct; 31(19):3151-4. PubMed ID: 7150344
    [No Abstract]   [Full Text] [Related]  

  • 11. An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.
    Steventon GB; Waring RH; Williams AC
    Drug Metabol Drug Interact; 2003; 19(4):223-40. PubMed ID: 14768972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic sulphoxidation of carbocisteine.
    Meese CO; Hofmann U; Eichelbaum M
    Lancet; 1990 Sep; 336(8716):693-4. PubMed ID: 1975882
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of polysaccharide peptide (PSP) on in vivo sulphation and glucuronidation of paracetamol in the rat.
    Yeung JH; Chiu LC; Ooi VE
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):287-92. PubMed ID: 8983934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically determined impaired drug sulphoxidation.
    Waring RH; Mitchell SC; Idle JR; Smith RL
    Lancet; 1981 Apr; 1(8223):778. PubMed ID: 6110975
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status.
    Emery P; Bradley H; Arthur V; Tunn E; Waring R
    Br J Rheumatol; 1992 Jul; 31(7):449-51. PubMed ID: 1628166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cirrhosis on sulphation by the isolated perfused rat liver.
    Choo EF; Angus PW; Morgan DJ
    J Hepatol; 1999 Mar; 30(3):498-502. PubMed ID: 10190735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile salt sulphation in man. Liver bile salt sulphotransferase activity in patients with primary biliary cirrhosis.
    Lööf L; Nyberg A
    Ups J Med Sci; 1983; 88(1):1-8. PubMed ID: 6575490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse influence of pregnancy upon sulphation: a clue to the pathogenesis of intrahepatic cholestasis of pregnancy?
    Davies MH; Ngong JM; Yucesoy M; Acharya SK; Mills CO; Weaver JB; Waring RH; Elias E
    J Hepatol; 1994 Dec; 21(6):1127-34. PubMed ID: 7699239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired sulfoxidation in patients with primary biliary cirrhosis.
    Scharschmidt BF; Lake JR
    Hepatology; 1989 Apr; 9(4):654-5. PubMed ID: 2925168
    [No Abstract]   [Full Text] [Related]  

  • 20. Intestinal absorption of cholecalciferol in alcoholic liver disease and primary biliary cirrhosis.
    Barragry JM; Long RG; France MW; Wills MR; Boucher BJ; Sherlock S
    Gut; 1979 Jul; 20(7):559-64. PubMed ID: 226459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.